Medication-assisted treatment is the use of FDA-approved medications in combination with counseling and behavioral therapies to provide a “whole-patient” approach to the treatment of Opioid Use Disorder. In Idaho, the two primary medications used in medication-assisted treatment are methadone and buprenorphine [suboxone].
To prescribe buprenorphine/suboxone, qualified physicians, physician assistants, and nurse practitioners must complete a training and apply for a DATA 2000 Waiver, also called an X-license, to treat Opioid Use Disorder with approved products in any setting in which they are qualified to practice. This required training is currently being offered for free in Idaho. Continue reading
Drug-induced deaths have increased in Idaho since 2010, but an updated report shows that the state remains slightly lower than the national average for this number. In 2016, the most recent year for which confirmed data is available, Idaho ranked 36th in the age-adjusted rate of drug-induced deaths by state, according to the Idaho Opioid Needs Assessment, which was released today by the Division of Behavioral Health.
A couple other highlights from the report include:
- Since reaching a peak in 2010-2012, several indicators appear to show a modest decrease in non-heroin opiate/synthetic use in Idaho over recent years.
- However, in 2016 Idaho was above the national average for the rate of opioids dispensed per 100,000 population and many indicators suggest that Idaho has experienced a significant increase in heroin use over the past decade.